Aiforia - Automating pathology with image recognition software

@Antti_Luiro ja @Frans-Mikael_Rostedt har gjort en utmärkt kvalitativ analys som dessutom är gratis! :open_mouth:

Aiforia’s H2 was largely in line with our expectations and the company’s sales pipeline is still promising. We still consider the company’s competitive position as good and if Aiforia continues winning customers as expected, the potential will gradually begin to emerge more clearly in revenue. On the other hand, poor growth predictability and elevated financial risks argue for some caution in pricing the potential.

2 gillningar